The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 19%.
The St. Joe Company
JOE · the NYSE · USD · Market cap $3.7B · 906 employees
The St.
FAIL · Does not pass the screenScreen close, 2026-10-02 · not a live quote
Screened 2026-10-02 · the tape above runs as of 13:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 65.38 against the desk's fair-value range, base estimate 32.69, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
The St. Joe Company holds its Markdown at $65.38. Elevated stress, defensive posture warranted, held for 8 days.
| Phase | Markdown · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 8 days |
| Price at the screen | $65.38 |
| Valuation | 30.69 trailing · 594.36 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.29 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 37.72% | Below 33% | Interest-bearing debt is 37.7% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 11.11% | Below 49% | Money owed to the company is 11.1% of assets, under the 49% limit. | Pass |
| Revenue purity | 2.56% | Below 5% | Only 2.6% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
The St. Joe's business is in a permissible area, but its interest-bearing debt is about 38% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-10-02 screen. The gold marker is the market price at the same screen. The price runs 50.0% above the base estimate.
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-02 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFlorida land bets priced far beyond reason
Picture a developer turning raw Florida acres into homes, hotels and offices. The St. Joe Company does exactly that across its residential, hospitality and commercial units, yet the market values the whole business at twice our calculated worth. Revenue edges up just five percent a year while the forward multiple sits at 550 times earnings, an absurd price for steady but unremarkable property work.
We pass because nothing in the numbers justifies the stretch. Profit margins of 22 percent and a 15 percent return on equity look respectable on their own, yet they cannot support such a premium when growth stays modest and the moat remains unclear. The ethical screen clears, which removes one objection, but valuation alone rules this out.
Real estate cycles can flatten earnings quickly and leave high multiples stranded, so the gap between price and fair value carries real downside. Analysis, not advice.
| Forward P/E | 594.4xexpensive even after accounting for its growth |
| Trailing P/E | 30.7xa premium valuation |
| EPS, trailing | 2.13 |
| EPS, forward | 0.11 |
| Revenue growth | +23.0%strong top-line growth |
| Profit margin | 22.5%healthy profit margins |
| Return on equity | 16.2%a solid return on shareholder capital |
| FCF yield | 3.19% |
| Dividend yield | 99.00% |
| Debt to equity | 0.71moderate, manageable leverage |
| Current ratio | 3.84comfortably covers its short-term bills |
| Beta | 1.29moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 46.37 - 73.54 |
| Market cap | $3.7B |
| Employees | 906 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeJOE trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 14.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 19%.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 19%.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 19%.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Is St. Joe (JOE) Expensive Or Undervalued On Its Mixed Valuation Signals? Simply Wall St. · 19 Aug 2026
- Billionaire Bruce Berkowitz Reveals 76% Of Fairholme Capital Is in Just 1 Stock 24/7 Wall St. · 18 Aug 2026
- Alico 3Q Revenue Jumps on Booming Land Management Strategy – Quarterly Update Report Exec Edge · 12 Aug 2026
- St. Joe (JOE) Q2 2026 Earnings Call Transcript Motley Fool · 8 Aug 2026
- The St. Joe Co (JOE) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Buybacks ... GuruFocus.com · 31 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $64.94 | -0.7% | $0.16 | $995 | -0.5% |
| 2 months | $67.20 | -4.1% | $0.16 | $962 | -3.8% |
| 3 months | $69.23 | -6.9% | $0.16 | $934 | -6.6% |
| 6 months | $61.84 | +4.3% | $0.32 | $1,048 | +4.8% |
| 1 year | $47.15 | +36.8% | $0.76 | $1,384 | +38.4% |
| 2 years | $53.33 | +20.9% | $1.18 | $1,231 | +23.1% |
| 3 years | $44.12 | +46.1% | $1.66 | $1,499 | +49.9% |
| 5 years | $46.41 | +38.9% | $2.42 | $1,441 | +44.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever JOE does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.